Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines
- PMID: 10973797
- DOI: 10.1006/bbrc.2000.3379
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines
Abstract
A variety of humoral factors modulate the osteoclastogenesis. Receptor activator of NF-kappaB ligand (RANKL) expressed on osteoblast/stromal lineage cells plays a pivotal role to transduce an essential differentiation signal to osteoclast lineage cells through binding to its receptor, RANK, expressed on the latter cell population; however, the difficulty to detect RANKL protein expression hampers us in investigating the regulation of RANKL expression by humoral factors. To determine protein expression of RANKL, we have established a new method, named as a ligand-receptor precipitation (LRP) Western blot analysis, which can specifically concentrate the _target protein by the use of specific binding characteristic between RANKL and RANK/osteoprotegrin (OPG). RANKL protein expression in the postnuclear supernatant was not detected by common Western blotting, but LRP Western blot analysis clearly showed that RANKL is produced as a membrane-bound protein on murine osteoblasts/stromal cells, and cleaved into a soluble form by metalloprotease. Cytokines stimulating the osteoclastogenesis, such as IL-1beta, IL-6, IL-11, IL-17, and TNF-alpha, increased the expression of RANKL with decrease of OPG expression in osteoblasts/stromal cells. In contrast, cytokines inhibiting the osteoclastogenesis, such as IL-13, INF-gamma, and TGF-beta1 suppressed the expression of RANKL and/or augmented OPG expression. Functional difference between membrane-bound and soluble RANKL was demonstrated, which showed that membrane-bound RANKL works more efficiently than soluble RANKL in the osteoclastogenesis developed from murine bone marrow cell culture. The present study indicates the usefulness of LRP Western blot analysis, which shows that the modulation of osteoclastogenesis by humoral factors is achieved, in part, by regulation of the expression of RANKL and OPG in osteoblast/stromal lineage cells.
Copyright 2000 Academic Press.
Similar articles
-
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459. J Bone Miner Res. 2000. PMID: 10934644
-
Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.J Endocrinol. 2005 Jun;185(3):401-13. doi: 10.1677/joe.1.05995. J Endocrinol. 2005. PMID: 15930166
-
Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.J Bone Miner Res. 2001 Jun;16(6):1004-14. doi: 10.1359/jbmr.2001.16.6.1004. J Bone Miner Res. 2001. PMID: 11393777
-
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.Cancer. 2003 Feb 1;97(3 Suppl):802-12. doi: 10.1002/cncr.11134. Cancer. 2003. PMID: 12548579 Review.
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
Cited by
-
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.Bone Rep. 2020 Jun 26;13:100291. doi: 10.1016/j.bonr.2020.100291. eCollection 2020 Dec. Bone Rep. 2020. PMID: 32637467 Free PMC article.
-
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.Front Immunol. 2018 Aug 10;9:1822. doi: 10.3389/fimmu.2018.01822. eCollection 2018. Front Immunol. 2018. PMID: 30147691 Free PMC article. Review.
-
The Influence of TLR4, CD14, OPG, and RANKL Polymorphisms in Periodontitis: A Case-Control Study.Mediators Inflamm. 2019 Jun 9;2019:4029217. doi: 10.1155/2019/4029217. eCollection 2019. Mediators Inflamm. 2019. PMID: 31281226 Free PMC article.
-
Effects of Administration of Amlodipine and Lacidipine on Inflammation-Induced Bone Loss in the Ovariectomized Rat.Inflammation. 2016 Feb;39(1):336-346. doi: 10.1007/s10753-015-0254-6. Inflammation. 2016. PMID: 26412256
-
Omega-3 fatty acids as an adjunct for periodontal therapy-a review.Clin Oral Investig. 2016 Jun;20(5):879-94. doi: 10.1007/s00784-016-1750-2. Epub 2016 Feb 17. Clin Oral Investig. 2016. PMID: 26885664 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous